Want to join the conversation?
$MU's cash flows from operations were $1.03Bil and CapEx was $1.85Bil in 4Q15. $MU ended 4Q15 with cash and marketable investments of $5.63Bil. In FY15, $MU initiated a series of actions to restructure its debt, which resulted in aggregate losses of $1MM, $18MM and $30MM in 4Q15, 3Q15 and 1Q15, respectively.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.